META-ANALYSES OF OVERALL SURVIVAL IN METASTATIC RENAL CELL CARCINOMA

被引：0
|
作者：
Wiecek, W. [1 ]
Nikodem, M. [2 ]
Karcher, H. [1 ]
机构：
[1] LASER Analyt, London, England
[2] LASER Analyt, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1660
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN38
引用
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [31] The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies
    Zhanchen Liao
    Zhitao Fang
    Siqi Gou
    Yong Luo
    Yiqi Liu
    Zhun He
    Xin Li
    Yansong Peng
    Zheng Fu
    Dongjin Li
    Haiyun Chen
    Zhigang Luo
    BMC Medicine, 20
  • [32] On meta-analyses of meta-analyses
    Ioannidis, JPA
    Lau, J
    LANCET, 1996, 348 (9029): : 756 - 756
  • [33] Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma
    Zhao, Juping
    Huang, Xin
    Sun, Fukang
    Ma, Renyi
    Wang, Haofei
    Shao, Kun
    Zhu, Yu
    Zhou, Wenlong
    Xu, Zhaoping
    Shen, Zhoujun
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (11-12): : E821 - E827
  • [34] Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
    Chen, Viola J.
    Hernandez-Meza, Gabriela
    Agrawal, Prashasti
    Zhang, Chiyuan A.
    Xie, Lijia
    Gong, Cynthia L.
    Hoerner, Christian R.
    Srinivas, Sandy
    Oermann, Eric K.
    Fan, Alice C.
    CANCERS, 2019, 11 (07)
  • [35] Overall survival with or without brain metastases from diagnosis of metastatic renal cell carcinoma.
    Bowman, I. Alex
    Christie, Alana
    Le, Tri Cao
    Bent, Alisha
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [37] SYSTEMATIC REVIEW AND META-ANALYSIS OF TARGETED THERAPY FOR OVERALL SURVIVAL, COMPLETE RESPONSE AND QUALITY OF LIFE FOR METASTATIC RENAL CELL CARCINOMA
    Han, Yong
    Wietsma, Ashley
    Gross, Cary
    Shah, Nilay
    Abouassaly, Robert
    Smaldone, Marc
    Boorjian, Stephen
    Hoimes, Christopher
    Cooney, Matthew
    Kim, Simon
    JOURNAL OF UROLOGY, 2015, 193 (04): : E869 - E870
  • [38] Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies (vol 53, pg 20, 2017)
    Kundu, Madan G.
    Acharyya, Suddhasatta
    CONTEMPORARY CLINICAL TRIALS, 2017, 60 : 126 - 126
  • [39] COMPARING SURVIVAL EXTRAPOLATION OUTCOMES USING DIFFERENT NETWORK META-ANALYSES (NMA) METHODS: AN APPLICATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH IMMUNOTHERAPY (IO) BASED COMBINATIONS
    Krol, F.
    Depalma, S.
    El Alili, H.
    Verhoek, A.
    van Beekhuizen, S.
    Heeg, B.
    VALUE IN HEALTH, 2022, 25 (12) : S359 - S359
  • [40] Risk factors for overall and cancer-specific survival of renal cell carcinoma: bilateral renal cell carcinoma does not influence overall and cancer-specific survival of renal cell carcinoma
    Wu, Y. -P.
    Jiang, T.
    Chen, S. -H.
    Ke, Z. -B.
    Liang, Y. -C.
    Xu, N.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 197 - 197
12345